Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy

Front Oncol. 2021 May 14:11:694578. doi: 10.3389/fonc.2021.694578. eCollection 2021.

Umberto Malapelle¹, Etienne Giroux Leprieur^{2

3}, Paul Takam Kamga³, Marius Tresor Chiasseu^{4

5}, Christian Rolfo⁶

¹ Department of Public Health, University of Naples Federico II, Naples, Italy.
² Department of Respiratory Diseases and Thoracic Oncology, APHP-Hopital Ambroise Pare, Boulogne-Billancourt, France.
³ EA 4340 BECCOH, UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
⁴ Cellular Neuroscience, Neurodegeneration and Repair Program, Yale University School of Medicine, New Haven, CT, United States.
⁵ Departments of Neurology, Yale University School of Medicine, New Haven, CT, United States.
⁶ Thoracic Medical Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Baltimore, MD, United States.

No abstract available

Keywords: NGS; NSCLC; biomarkers; diagnosis; therapy.

Publication types